Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Jacobs

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Pharmaceutics|December 21, 2021
Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZenecaAkosua B Anane-Adjei, Esther Jacobs, Samuel C Nash, et al.
Molecular Pharmaceutics|October 2, 2025
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution EnhancementMartin A Screen, Sean Askin, James F McCabe, et al.
BMC Public Health|December 5, 2018
Regional differences of macrovascular disease in Northeast and South Germany: the population-based SHIP-TREND and KORA-F4 studiesVioletta Ptushkina, Esther Jacobs, Sabine Schipf, et al.
Thrombosis and Haemostasis|January 27, 2026
Biomarkers in relation to patency, popliteal reflux and post-thrombotic syndromeRuben Hupperetz, Aaron Iding, Jorinde H H van Laanen, et al.
Trials|September 15, 2017
Specific barriers to the conduct of randomised clinical trials on medical devicesEdmund A M Neugebauer, Ana Rath, Sunya-Lee Antoine, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Pharmaceutics|December 21, 2021
Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZenecaAkosua B Anane-Adjei, Esther Jacobs, Samuel C Nash, et al.
Molecular Pharmaceutics|October 2, 2025
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution EnhancementMartin A Screen, Sean Askin, James F McCabe, et al.
BMC Public Health|December 5, 2018
Regional differences of macrovascular disease in Northeast and South Germany: the population-based SHIP-TREND and KORA-F4 studiesVioletta Ptushkina, Esther Jacobs, Sabine Schipf, et al.
Thrombosis and Haemostasis|January 27, 2026
Biomarkers in relation to patency, popliteal reflux and post-thrombotic syndromeRuben Hupperetz, Aaron Iding, Jorinde H H van Laanen, et al.
Trials|September 15, 2017
Specific barriers to the conduct of randomised clinical trials on medical devicesEdmund A M Neugebauer, Ana Rath, Sunya-Lee Antoine, et al.
Pageof 2